GENE(Delisted)
Genetic TechnologiesยทNASDAQ
--
--(--)
GENE fundamentals
Genetic Technologies (GENE) released its earnings on Aug 31, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 31, 2021
EPS
Revenue
Revenue & Expenses
Key Indicators
Genetic Technologies (GENE) key financial stats and ratios, covering profitability, financial health, and leverage.
Genetic Technologies (GENE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Genetic Technologies (GENE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Genetic Technologies (GENE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Genetic Technologies (GENE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Genetic Technologies (GENE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
